Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2007-11-21

Clinical Trial Update: Nimotuzumab in Children With HGG

View source ↗

Summary

A completed clinical trial investigating Nimotuzumab in children with high-grade glioma; the update notes trial status without detailing results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Nimotuzumab (nimotuzumab)

Snippet

Sponsor: Oncoscience AG | Conditions: High Grade Glioma | Status: COMPLETED